# Traumatic Brain Injury and Effects of Acute Cyclosporine A

> **NCT02496975** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Edward Hall,PhD**

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** Cyclosporine A
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02496975
- **Lead sponsor:** Edward Hall,PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-08-07
- **Primary completion:** 2017-08-07
- **Final completion:** 2017-08-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Recent studies suggest that cyclosporine A has a very sharp biphasic dose-response problem that is going to make further clinical translation difficult.
- **Last updated:** 2017-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02496975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02496975, "Traumatic Brain Injury and Effects of Acute Cyclosporine A". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02496975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*